The higher the HER2 expression, the more benefit patients get from the antibody-drug conjugate trastuzumab deruxtecan (Enhertu) for HER2-positive metastatic colorectal cancer in the salvage
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
